RegonolActive Ingredient(s): Pyridostigmine
FDA Approved: * August 14, 1973
Pharm Company: * SANDOZ
Category: Myasthenic Syndrome
Pyridostigmine is a medication used to treat myasthenia gravis and underactive bladder. It is also used together with atropine to end the effects of neuromuscular blocking medication of the non-depolarizing type. It is typically given by mouth but can also be used by injection. The effects generally begin within 45 minutes and last up to 6 hours. Common side effects include nausea, diarrhea, frequen... [wikipedia]* May have multiple approval dates, manufacturers, or labelers.